RAY1225
A Study of RAY1225 in Participants With Obesity
Guangdong Raynovent Biotech Co · Phase 2 · Recruiting · Enrollment 270
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| RAY1225 (cohort 1) | n/r | n/r | n/r | n/r | n/r |
| Placebo (cohort 1) | n/r | n/r | n/r | n/r | n/r |
| RAY1225 (cohort 2) | n/r | n/r | n/r | n/r | n/r |
| Placebo (cohort 2) | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.